Read more about the article Patient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda
Patient Recruitment in Clinical Trials - From Recruitment Challenges to Successful Enrollment - Insights from Lambda CRO

Patient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda

Bringing a new therapy to patients depends on more than scientific innovation. It depends on identifying, enrolling, and retaining the right participants within planned timelines. Yet patient recruitment remains one…

Continue ReadingPatient Recruitment in Clinical Trials: From Recruitment Challenges to Successful Enrollment | Insights from Lambda
Read more about the article FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases
FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases

FDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases

The agency's new "Plausible Mechanism Framework" creates a first-of-its-kind regulatory pathway for genome editing and RNA-based therapies targeting small patient populations where traditional clinical trials are not feasible. The U.S.…

Continue ReadingFDA Launches Framework to Accelerate Individualized Therapies for Ultra-Rare Diseases
Read more about the article Patient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope
World Cancer Day - Patient-Centric Oncology Clinical Trials in Advancing Cancer Research - Lambda CRO

Patient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope

On World Cancer Day, we recognize the importance of cancer research in expanding early access to investigational therapies and generating evidence that informs progress in oncology care. At Lambda Therapeutic…

Continue ReadingPatient-Centric Trials in Advancing Cancer Research: A Journey of Progress & Hope
Read more about the article EMA and FDA Publish Common Principles for AI in Drug Development
EMA and FDA Publish Common Principles for AI in Drug Development - Lambda CRO

EMA and FDA Publish Common Principles for AI in Drug Development

Artificial intelligence is increasingly being applied across the medicine development lifecycle, including early research, clinical trials, manufacturing, and safety monitoring. As the use of AI expands, regulatory clarity has become…

Continue ReadingEMA and FDA Publish Common Principles for AI in Drug Development